Quantitative Systematic Strategies LLC Catalyst Biosciences, Inc. Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$3.78 - $5.18 $61,527 - $84,314	-16,277 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$4.1 - $5.33 $56,251 - $73,127	-13,720 Reduced 45.74%	16,277 $70,000
Q1 2021 May 06, 2021	BUY	$4.93 - $7.15 $147,885 - $214,478	29,997 New	29,997 $151,000
Q1 2019 Apr 15, 2019	SELL	$7.67 - $9.96 $86,624 - $112,488	-11,294 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$6.59 - $11.28 $74,427 - $127,396	11,294 New	11,294 $89,000

Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $96,202 - $127,995	-10,289 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$9.11 - $28.88 $93,732 - $297,146	10,289 New	10,289 $120,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.